PAULA GILL, MD
Hematology & Oncology Physician · LA CROSSE, WI
Individual Active NPI 1750363909
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 538 | 75,491 | $6,676,952 | $2,163,353 | $1,723,645 |
| 2023 | 502 | 69,927 | $6,014,713 | $1,943,998 | $1,547,025 |
| 2022 | 361 | 27,080 | $2,307,629 | $803,788 | $639,052 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 10,402 | $53 | $42 |
| J1453 | Injection, fosaprepitant, 1 mg | 8,400 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 6,663 | $49 | $39 |
| J9267 | Injection, paclitaxel, 1 mg | 5,352 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 4,245 | $29 | $23 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 4,100 | $0 | $0 |
| J9305 | Injection, pemetrexed, not otherwise specified, 10 mg | 1,110 | $4 | $3 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,032 | $0 | $0 |
| J9041 | Injection, bortezomib, 0.1 mg | 1,015 | $2 | $1 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 960 | $1 | $1 |
| Q5115 | Injection, rituximab-abbs, biosimilar, (truxima), 10 mg | 840 | $32 | $26 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 552 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 48413 | WI |
| Hematology & Oncology Physician | 207RH0003X | 44978 | MN |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Wisconsin
- NPI 1164688834
- NPI 1417036005
- NPI 1851412555
- NPI 1104265339
- NPI 1467457432
- NPI 1922259589
- NPI 1770585051
- NPI 1245336759
See all Hematology & Oncology Physician providers in Wisconsin →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.